Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2017 Jul;63(7):1187-1189.
doi: 10.1373/clinchem.2016.268565. Epub 2017 May 17.

Leveraging Human Genetics to Understand the Relation of LDL Cholesterol with Type 2 Diabetes

Erik Ingelsson  1   2 , Joshua W Knowles  3   2
Affiliations
Comment

Leveraging Human Genetics to Understand the Relation of LDL Cholesterol with Type 2 Diabetes

Erik Ingelsson et al. Clin Chem. 2017 Jul.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflicts of interest

Dr. Ingelsson is a scientific advisor and consultant for Precision Wellness, Inc. and scientific advisor for Cellink for work unrelated to this paper. Dr. Knowles is Chief Medical Advisor for FH Foundation, a nonprofit organization dedicated to education, advocacy, and research of familial hypercholesterolemia.

Comment on

  • Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis.
    Lotta LA, Sharp SJ, Burgess S, Perry JRB, Stewart ID, Willems SM, Luan J, Ardanaz E, Arriola L, Balkau B, Boeing H, Deloukas P, Forouhi NG, Franks PW, Grioni S, Kaaks R, Key TJ, Navarro C, Nilsson PM, Overvad K, Palli D, Panico S, Quirós JR, Riboli E, Rolandsson O, Sacerdote C, Salamanca EC, Slimani N, Spijkerman AM, Tjonneland A, Tumino R, van der A DL, van der Schouw YT, McCarthy MI, Barroso I, O'Rahilly S, Savage DB, Sattar N, Langenberg C, Scott RA, Wareham NJ. Lotta LA, et al. JAMA. 2016 Oct 4;316(13):1383-1391. doi: 10.1001/jama.2016.14568. JAMA. 2016. PMID: 27701660 Free PMC article.

References

    1. Lotta LA, Sharp SJ, Burgess S, Perry JR, Stewart ID, Willems SM, et al. Association Between Low-Density Lipoprotein Cholesterol-Lowering Genetic Variants and Risk of Type 2 Diabetes: A Meta-analysis. JAMA. 2016;316(13):1383–91. - PMC - PubMed
    1. Schmidt AF, Swerdlow DI, Holmes MV, Patel RS, Fairhurst-Hunter Z, Lyall DM, et al. PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study. Lancet Diabetes Endocrinol. 2016 Nov 28; doi: 10.1016/S2213-8587(16)30396-5. [Epub ahead of print] - DOI - PMC - PubMed
    1. Fall T, Xie W, Poon W, Yaghootkar H, Magi R, Consortium G et al. Using Genetic Variants to Assess the Relationship Between Circulating Lipids and Type 2 Diabetes. Diabetes. 2015;64(7):2676–84. - PubMed
    1. Ference BA, Robinson JG, Brook RD, Catapano AL, Chapman MJ, Neff DR, et al. Variation in PCSK9 and HMGCR and Risk of Cardiovascular Disease and Diabetes. N Engl J Med. 2016;375(22):2144–53. - PubMed
    1. Kohli P, Knowles JW, Sarraju A, Waters DD, Reaven G. Metabolic Markers to Predict Incident Diabetes Mellitus in Statin-Treated Patients (from the Treating to New Targets and the Stroke Prevention by Aggressive Reduction in Cholesterol Levels Trials) Am J Cardiol. 2016;118(9):1275–81. - PMC - PubMed

Publication types